Genes related to growth and invasiveness are repressed by sodium butyrate in ovarian carcinoma cells

British Journal of Cancer

Volumn 73, Issue 4, 1996, Pages 433-438

  Krupitza, G ^a   Grill, S ^a   Harant, H ^b   Hulla, W ^a   Szekeres, T ^c   Huber, H ^a   Dittrich, C ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b KAISER FRANZ JOSEF HOSPITAL   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Butyrate; Ovarian cancer; Prad1; Urokinase

Indexed keywords

BUTYRIC ACID; CALCIUM ION; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLINE; FIBRONECTIN; PROTEIN KINASE C; UROKINASE;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INACTIVATION; GENE EXPRESSION REGULATION; GENE REPRESSION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; ONCOGENE; OVARY CARCINOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0030039901     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.78     Document Type: Article

References (31)

1. AMSTAD P, KRUPITZA G AND CERUTTI P. (1992). Mechanisms of c-fos induction by active oxygen. Cancer Res., 52, 3952-3960.
2. ARNOLD A, KIM H, GAZ R, EDDY R, FUKUSHIMA Y, BYERS M, SHOWS T AND KRONENBERG H. (1989). Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J. Clin. Invest., 83, 2034-2040.
3. AXELROD J, REICH R AND MISHKIN R. (1989). Expression of human recombinant plasminogen activator enhances invasion and experimental metastasis of H-ras transformed NIH-3T3 cells. Mol. Cell. Biol., 9, 2133-2141.
4. BLOCH A. (1984). Induced cell differentiation in cancer therapy. Cancer Treat. Rep., 68, 199-205.
5. BUCKLEY M, SWEENEY K, HAMILTON J, SINI R, MANNING D, NICHOLSON R, deFAZIO J, WATTS C, MUSGROVE E AND SUTHERLAND R. (1993). Expression and amplification of cyclin genes in human breast cancer. Oncogene, 8, 2127-2133.
6. BUICK R, PULLANO R AND TRENT J. (1985). Comparative properties of five human ovarian adenocarcinoma cell lines. Cancer Res., 45, 3668-3676.
7. CASTAIGNE S, CHOMIENNE C, DANIEL M, BALLERINI P, BERGER R, FENAUX P AND DEGOS L. (1990). All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. clinical results. Blood, 76, 1704-1709.
8. CLAPHAM D. (1995). Calcium signaling. Celt, 80, 259-268.
9. DAKSIS J, LU R, FACCHINI L, MARHIN W AND PENN L. (1994). Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. Oncogene, 9, 3635-3645.
10. DOWDY S, HINDS P, LOUIE K, REED S, ARNOLD A AND WEINBERG R. (1993). Physical interaction of the retinoblastoma protein with human D cyclins. Cell, 73, 499-511.
11. FISCHKOFF S, HOESSLY M AND ROSSI R. (1990). Characterization of sublines of HL-60 human leukemia cells resistant to induction of differentiation by butyric acid. Leukemia, 4, 302-306.
12. GRUNT T, DITTRICH E, SOMAY C, WAGNER T AND DITTRICH C. (1991). Separation of clonogenic and differentiated cell phenotypes of ovarian cancer cells (HOC-7) by discontinuous density gradient centrifugation. Cancer Lett., 58, 7-16.
13. HAGUE A, MANNING A, HANLOW K, HUSCHTSCHA L, HART D AND PARASKEVA C. (1993). Sodium butyrate induces apoptosis in human colonie tumor cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large bowel cancer. Int. J. Cancer, 55, 498-505.
14. HEROLD K AND ROTHBERG P. (1988). Evidence for a labile intermediate in the butyrate induced reduction of the level of c-myc RNA in SW837 rectal carcinoma cells. Oncogene, 3, 423-428.
15. JIANG W, KAHN S, ZHOU P, ZHANG Y, CACACE A, INFANTE A, DOI S, SANTELLA R AND WEINSTEIN B. (1993). Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene, 8, 3447-3457.
16. KARLSEN AE, FUJIMOTO WY, RABINOVITCH P, DUBE S AND LERNMARK A. (1991). Effects of sodium butyrate on proliferation dependent insulin gene expression and insulin release in glucose sensitive RIN-5AH cells. J. Biol. Chem., 266, 7542-7548.
17. KRUPITZA G, HULLA W, HARANT H, DITTRICH E, KALLAY E, HUBER H, GRUNT T AND DITTRICH C. (1995a). Retinoic acid induced death of ovarian carcinoma cells correlates with c-myc stimulation. Int. J. Cancer, 61, 649-657.
18. KRUPITZA G, HARANT H, DITTRICH E, SZEKERES T, HUBER H AND DITTRICH C. (1995b). Sodium butyrate inhibits c-myc splicing and interferes with signal transduction in ovarian carcinoma cells. Carcinogenesis, 16, 1199-1205.
19. KRUPITZA G, KRITSCHE R, DITTRICH E, HARANT H, HUBER H, GRUNT T AND DITTRICH C. (1995c). Macrophage colony-stimulating factor is expressed by an ovarian carcinoma subline and stimulates the c-myc proto-oncogene. Br. J. Cancer, 72, 35-40.
20. LEE D, HAYES J, PRUSS D AND WOLFFE A. (1993). A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell, 72, 73-84.
21. LIOTTA L, STEEG P AND STETLER-STEVENSON W. (1991). Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell, 64, 327-336.
22. LIPPMAN S, PARKINSON D, ITRI L, WEBER R, SCHANTZ S, OTA D, SCHUSTERMAN M, KRAKOFF I, GUTTERMAN J AND HONG W. (1992). 13-cis retinoic acid and interferon alpha-2a: Effective combination therapy for advanced squamous cell carcinoma of the skin. J. Natl Cancer Inst., 84, 235-241.
23. LUKAS J, PAGANO M, STASKOVA Z, DRAETTA G AND BARTEK J. (1994). Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumor cell lines. Oncogene, 9, 707-718.
24. MANFIOLETTI G, BRANCOLINI C, AVANZI G AND SCHNEIDER C. (1993). The protein encoded by a growth arrest specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol. Cell. Biol., 13, 4976-4985.
25. MARCU K, BOSSONE S AND PATEL A. (1992). myc function and regulation. Annu. Rev. Biochem., 61, 809-860.
26. MONTGOMERY A, DeCLERCK Y, LANGLEY K, REISFELD R AND MUELLER B. (1993). Melanoma-mediated dissolution of extracellular matrix: contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways. Cancer Res., 53, 693-700.
27. NOVOGRODSKY A, DVIR A, RAVID A, SHKOLNIK T, STENZEL K, RUBIN A AND ZAIZOV R. (1983). Effect of polar organic compounds on leukemic cells: Butyrate induced partial remission of acute myelogenous leukemia in a child. Cancer, 51, 9-14.
28. RABBITTS, TH. (1991). Translocations, master genes, and differences between the origins of acute and chronic leukemias. Cell, 67, 641-644.
29. RUOSLAHTI E. (1988). Fibronectin and its receptors. Annu. Rev. Biochem., 57, 375-413.
30. SCHNEIDER C, KING R AND PHILIPSON L. (1988). Genes specifically expressed at growth arrest of mammalian cells. Cell, 54, 787-793.
31. STAIANO-COICO L AND HIGGINS P. (1992). Cell shape changes during transition of basal keratinocytes to mature enucleate-cornified envelopes: Modulation of terminal differentiation by fibronectin. Exp. Cell Res., 201, 126-136.